BR112019003609A2 - remédio para profilaxia de leucemia bovina e método de uso. - Google Patents
remédio para profilaxia de leucemia bovina e método de uso.Info
- Publication number
- BR112019003609A2 BR112019003609A2 BR112019003609A BR112019003609A BR112019003609A2 BR 112019003609 A2 BR112019003609 A2 BR 112019003609A2 BR 112019003609 A BR112019003609 A BR 112019003609A BR 112019003609 A BR112019003609 A BR 112019003609A BR 112019003609 A2 BR112019003609 A2 BR 112019003609A2
- Authority
- BR
- Brazil
- Prior art keywords
- bovine leukemia
- prevention
- leukemia
- drug
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/804—Blood cells [leukemia, lymphoma]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
a invenção geralmente se refere ao campo de medicina veterinária e pode ser usado para prevenção de leucemia bovina. a invenção expande a faixa dos meios da aplicação reivindicada e fornece a resistência vitalícia aos animais ao vírus da leucemia. a invenção tem o objetivo de resolver o problema de expandir a faixa de medicamentos preventivos e formar novas abordagens ao problema de prevenção de leucemia bovina, que possibilita garantir a resistência vitalícia dos animais a infecção por leucemia. o resultado técnico consiste do projeto de um remédio e seu uso para prevenção de leucemia bovina, que permitiria oferecer uma resposta imune direcionada, com eficiência e baixos custos, ativando a imunidade celular contra o vírus de leucemia bovina aumentando o número de células exterminadoras. o remédio para prevenção de leucemia bovina contém uma fração proteica solúvel em água com peso molecular de 18-20 kda, isolado dos produtos da destruição de micobactéria de tuberculose, caracterizados pela presença de picos perto de um comprimento de onda de 214 nm na região uv, uma solução salina tamponada por fosfato, uma solução aquosa de formaldeído e uma solução isotônica de cloreto de sódio. o uso consiste na administração do referido remédio a bezerros com idade de 1 a 9 dias com injeção intramuscular única em uma dose de 4,0-6,0 ml per capita.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016145862A RU2631607C1 (ru) | 2016-11-22 | 2016-11-22 | Средство для профилактики лейкоза крупного рогатого скота и способ его применения |
| PCT/RU2017/000404 WO2018097750A1 (ru) | 2016-11-22 | 2017-06-13 | Средство для профилактики лейкоза крупного рогатого скота и способ его применения |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019003609A2 true BR112019003609A2 (pt) | 2019-07-09 |
Family
ID=59931316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019003609A BR112019003609A2 (pt) | 2016-11-22 | 2017-06-13 | remédio para profilaxia de leucemia bovina e método de uso. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10434163B2 (pt) |
| EP (1) | EP3403668A4 (pt) |
| CN (1) | CN109641040B (pt) |
| AU (1) | AU2017363399B2 (pt) |
| BR (1) | BR112019003609A2 (pt) |
| CA (1) | CA3018982C (pt) |
| MX (1) | MX2019002570A (pt) |
| RU (1) | RU2631607C1 (pt) |
| WO (1) | WO2018097750A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023048596A1 (ru) * | 2021-09-22 | 2023-03-30 | Владислав Николаевич ЛАСКАВЫЙ | Композиция для поддержания нормального состояния гомеостаза и препарат на её основе |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK79893D0 (da) * | 1993-07-02 | 1993-07-02 | Statens Seruminstitut | New vaccine |
| RU2146533C1 (ru) * | 1998-08-19 | 2000-03-20 | Ласкавый Владислав Николаевич | Способ профилактики туберкулеза молодняка крупного рогатого скота |
| JP4521687B2 (ja) * | 2002-06-21 | 2010-08-11 | ニューキャッスル イノベーション リミテッド | プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２ |
| WO2007121194A1 (en) * | 2006-04-10 | 2007-10-25 | The Regents Of The University Of California | Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use |
| RU2300883C2 (ru) * | 2005-08-29 | 2007-06-20 | Юрий Федорович Бардеев | Способ профилактики и лечения лейкоза крупного рогатого скота (варианты) |
| RU2392002C2 (ru) * | 2008-04-02 | 2010-06-20 | ФГОУ ВПО Курская государственная сельскохозяйственная академия им. профессора И.И. Иванова | Способ получения туберкулезного анатоксина |
| RU2390559C1 (ru) * | 2008-10-22 | 2010-05-27 | Государственное образовательное учреждение высшего профессионального образования Казанский государственный медицинский университет | Способ получения антигена из micobacterium tuberculosis |
| RU2396978C1 (ru) * | 2009-03-05 | 2010-08-20 | Федеральное государственное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова | Способ профилактики развития лейкоза крупного рогатого скота |
| RU2420275C1 (ru) * | 2009-12-16 | 2011-06-10 | Государственное научное учреждение Курский научно-исследовательский институт агропромышленного производства | Способ профилактики лейкоза крупного рогатого скота |
| KR101820026B1 (ko) * | 2011-01-04 | 2018-01-18 | 알치벨 팔마, 에스.엘. | 결핵을 치료하거나 예방하는데 적합한 리포솜 제형 |
| EP3038648A4 (en) * | 2013-08-30 | 2017-04-19 | Longhorn Vaccines and Diagnostics, LLC | Enhancing immunity to tuberculosis |
| RU2558924C1 (ru) * | 2014-07-15 | 2015-08-10 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский ветеринарный институт Нечернозёмной зоны Российской Федерации" | Способ профилактики лейкоза молодняка крупного рогатого скота |
-
2016
- 2016-11-22 RU RU2016145862A patent/RU2631607C1/ru active
-
2017
- 2017-06-13 WO PCT/RU2017/000404 patent/WO2018097750A1/ru active Application Filing
- 2017-06-13 EP EP17873383.8A patent/EP3403668A4/en not_active Withdrawn
- 2017-06-13 MX MX2019002570A patent/MX2019002570A/es unknown
- 2017-06-13 CN CN201780050553.XA patent/CN109641040B/zh active Active
- 2017-06-13 AU AU2017363399A patent/AU2017363399B2/en not_active Ceased
- 2017-06-13 CA CA3018982A patent/CA3018982C/en active Active
- 2017-06-13 BR BR112019003609A patent/BR112019003609A2/pt unknown
- 2017-12-11 US US15/836,943 patent/US10434163B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3403668A4 (en) | 2019-11-27 |
| MX2019002570A (es) | 2019-07-01 |
| CN109641040A (zh) | 2019-04-16 |
| AU2017363399A1 (en) | 2019-02-14 |
| US20180169207A1 (en) | 2018-06-21 |
| AU2017363399B2 (en) | 2019-09-26 |
| US10434163B2 (en) | 2019-10-08 |
| RU2631607C1 (ru) | 2017-09-25 |
| EP3403668A1 (en) | 2018-11-21 |
| WO2018097750A1 (ru) | 2018-05-31 |
| CA3018982A1 (en) | 2018-05-31 |
| CN109641040B (zh) | 2023-02-28 |
| CA3018982C (en) | 2022-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022023462A2 (pt) | 2-amino-3-ciano tiofenos anulados e derivados para o tratamento de câncer | |
| BR112018068719A2 (pt) | métodos para produzir uma resposta imunogênica em um animal aquático e composição farmacêutica | |
| Vajdy | Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems | |
| Khan et al. | Antiviral, embryo toxic and cytotoxic activities of Astragalus membranaceus root extracts | |
| BR112014026744A8 (pt) | anticorpo isolado ou fragmento de anticorpo, composição de anticorpo ou composição de fragmento de anticorpo, uso de modulação imune, uso de pelo menos uma composição de anticorpo ou fragmento de anticorpo, dispositivo médico, formulação, kit, artigo de fabricação para uso farmacêutico humano, método para produzir um anticorpo ou fragmento, animal ou planta transgênica, e, anticorpo ou porção ou variante especificada. | |
| Rommelfanger et al. | The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated mice | |
| Johnson-Weaver et al. | Mast cell activators as novel immune regulators | |
| Saeed et al. | Botanicals: A promising approach for controlling cecal coccidiosis in poultry | |
| BR112022010798A2 (pt) | Derivado de metileno-naftaleno-éter de fenilisoxazolila, seu uso e composição farmacêutica compreendendo o mesmo | |
| CL2023000740A1 (es) | Composiciones de vacunas multivalentes y usos de las mismas. | |
| BR112019003609A2 (pt) | remédio para profilaxia de leucemia bovina e método de uso. | |
| CO2022015272A2 (es) | Medicamento/agente para el tratamiento de coronavirus, infecciones retrovirales y hepatitis c | |
| BR112015029260A2 (pt) | derivados de tilosina e seu método de preparação | |
| BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
| Irais et al. | Plant phenolics as pathogen-carrier immunogenicity modulator haptens | |
| AR126757A1 (es) | Uso de un derivado de la ciclohexanetriona y de una composición farmacéutica que lo comprende en la preparación de medicamentos para animales | |
| BR112022007474A2 (pt) | Vacina de partículas semelhantes a vírus chikungunya e métodos de uso da mesma | |
| CL2013002829A1 (es) | Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv. | |
| US7815945B2 (en) | Medicament for the prevention and treatment of influenza | |
| Useh et al. | Anaemia in Clostridium chauvoei infection is masked by haemoconcentration. | |
| SHENDI et al. | EVALUATION OF OLIBANUM EXTRACT ACTIVITY AGAINST TRICHINELLA SPIRALIS ADULTS AND LARVAE: IN VITRO STUDY | |
| Phukan et al. | Comparative efficacy of certain drugs against stephanofilarial dermatitis in cattle | |
| Martens-Koop et al. | Intracellular Pathogens: Infection, Immunity, and Intervention | |
| MÃƒÆ et al. | In vitro behavior of Mycoplasmagallisepticum live-type nosode | |
| CA2622508A1 (en) | Medicament for the prevention and treatment of influenza |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |